Inhibition of N-linked glycosylation impairs ALK phosphorylation and disrupts pro-survival signaling in neuroblastoma cell lines
<p>Abstract</p> <p>Background</p> <p>The Anaplastic Lymphoma Kinase (ALK) is an orphan receptor tyrosine kinase, which undergoes post-translational N-linked glycosylation. The catalytic domain of ALK was originally identified in the t(2;5) translocation that produces th...
Main Authors: | Del Grosso Federica, De Mariano Marilena, Passoni Lorena, Luksch Roberto, Tonini Gian, Longo Luca |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-12-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/11/525 |
Similar Items
-
ALK in Neuroblastoma: Biological and Therapeutic Implications
by: Ricky M. Trigg, et al.
Published: (2018-04-01) -
Germline and Somatic ALK Alterations in Neuroblastoma Patients
by: Ana Catarina Marinho da Rocha
Published: (2019) -
Entrectinib and other ALK/TRK inhibitors for the treatment of neuroblastoma
by: Pacenta HL, et al.
Published: (2018-10-01) -
Role of the mutated ALK oncogene in neuroblastoma oncogenesis and in development
by: Delisle, Lucille
Published: (2015) -
5′ ALK Amplification in Neuroblastoma: A Case Report
by: Sara Akhavanfard, et al.
Published: (2021-03-01)